Tag: oesophageal squamous cell cancer

NICE nod for BMS’ Opdivo in advanced oesophageal cancer

by Lucy Parsons | May 14, 2021 | News | 0

Cost-effectiveness watchdog recommends first immunotherapy for unresectable advanced oesophageal cancer

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999